Jun 13, 2022 ENDO 2022 Poster Presentation 390.3 KB May 22, 2022 Comparison of hyperphagia and problem behaviors in participants with Prader-Willi syndrome (PWS) receiving Diazoxide Choline Extended-Release (DCCR) with matched participants in PATH for PWS (PfPWS) 2.3 MB May 05, 2021 Abstract 2739 Therapeutic Response to DCCR (Diazoxide Choline) Extended-Release Tablets in Patients with Prader-Willi Syndrome 116.5 KB May 05, 2021 A Phase III Study of DCCR in Prader-Willi Syndrome: Effects on Resting Energy Expenditure (REE) and Adiposity 202 KB May 05, 2021 Evaluation of Methods That Estimate Glomerular Filtration Rate in Patients With Prader-Willi Syndrome 170 KB May 04, 2021 Application of a semi-automated framework to characterize individual experiences with DCCR in Prader-Willi syndrome 318.8 KB Feb 04, 2021 Key Opinion Leader Meeting on DCCR for Treatment of Prader-Willi Syndrome 1.9 MB Nov 03, 2020 A Phase III Study of DCCR in Prader-Willi Syndrome: Effects on Body Composition and Adipokines 636 KB Jun 08, 2020 Soleno Therapeutics Phase III DESTINY PWS Trial Results 410.2 KB Nov 15, 2018 DCCR Fat Loss Poster Presentation at Obesity Society November 2018 215.5 KB Oct 04, 2018 DCCR Overall Safety Poster Presentation at FPWR October 2018 96 KB Oct 04, 2018 DCCR Mode of Action Oral Presentation at FPWR October 2018 2.4 MB Sep 29, 2018 DCCR Glycemic Impact - Poster Presentation at ESPE 2018 510.7 KB Sep 29, 2018 DCCR Pharmacokinetics -Poster Presentation at ESPE 2018.pdf 205.9 KB Sep 14, 2017 DCCR in PWS – Poster Presentation at the 10th International Meeting of Pediatric Endocrinology 500.5 KB P1-1161 Efficacy and Safety of Diazoxide Choline Controlled-Release Tablet in Patients with Prader-Willi syndrome, an Updated An 670.6 KB
May 22, 2022 Comparison of hyperphagia and problem behaviors in participants with Prader-Willi syndrome (PWS) receiving Diazoxide Choline Extended-Release (DCCR) with matched participants in PATH for PWS (PfPWS) 2.3 MB
Comparison of hyperphagia and problem behaviors in participants with Prader-Willi syndrome (PWS) receiving Diazoxide Choline Extended-Release (DCCR) with matched participants in PATH for PWS (PfPWS) 2.3 MB
May 05, 2021 Abstract 2739 Therapeutic Response to DCCR (Diazoxide Choline) Extended-Release Tablets in Patients with Prader-Willi Syndrome 116.5 KB
Abstract 2739 Therapeutic Response to DCCR (Diazoxide Choline) Extended-Release Tablets in Patients with Prader-Willi Syndrome 116.5 KB
May 05, 2021 A Phase III Study of DCCR in Prader-Willi Syndrome: Effects on Resting Energy Expenditure (REE) and Adiposity 202 KB
A Phase III Study of DCCR in Prader-Willi Syndrome: Effects on Resting Energy Expenditure (REE) and Adiposity 202 KB
May 05, 2021 Evaluation of Methods That Estimate Glomerular Filtration Rate in Patients With Prader-Willi Syndrome 170 KB
Evaluation of Methods That Estimate Glomerular Filtration Rate in Patients With Prader-Willi Syndrome 170 KB
May 04, 2021 Application of a semi-automated framework to characterize individual experiences with DCCR in Prader-Willi syndrome 318.8 KB
Application of a semi-automated framework to characterize individual experiences with DCCR in Prader-Willi syndrome 318.8 KB
Nov 03, 2020 A Phase III Study of DCCR in Prader-Willi Syndrome: Effects on Body Composition and Adipokines 636 KB
A Phase III Study of DCCR in Prader-Willi Syndrome: Effects on Body Composition and Adipokines 636 KB
Sep 14, 2017 DCCR in PWS – Poster Presentation at the 10th International Meeting of Pediatric Endocrinology 500.5 KB
DCCR in PWS – Poster Presentation at the 10th International Meeting of Pediatric Endocrinology 500.5 KB
P1-1161 Efficacy and Safety of Diazoxide Choline Controlled-Release Tablet in Patients with Prader-Willi syndrome, an Updated An 670.6 KB
P1-1161 Efficacy and Safety of Diazoxide Choline Controlled-Release Tablet in Patients with Prader-Willi syndrome, an Updated An 670.6 KB